Clinical Trial Update: Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing two treatment algorithms for adults with moderate to severe Crohn's disease; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Crohn's Disease | Phase 3 | Status: COMPLETED | Results posted: 2017-12-07